Previous close | 14.27 |
Open | 12.85 |
Bid | 10.70 |
Ask | 14.20 |
Strike | 500.00 |
Expiry date | 2025-01-17 |
Day's range | 12.85 - 12.85 |
Contract range | N/A |
Volume | |
Open interest | 230 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...